iwCLL 2019 | Is MRD ready for clinical practice?

Lydia Scarfò

Lydia Scarfò, MD, Vita-Salute San Raffaele University, Milan, Italy shares her opinion on measurable residual disease (MRD) and how we might be able to integrate this intermediate endpoint into clinical practice. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video